Dentsply Sirona (XRAY) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 34% Undervaluation?
Simply Wall StDec 21 07:57 ET
Dentsply Sirona Is Maintained at Overweight by Morgan Stanley
Dow JonesDec 17 12:12 ET · Ratings
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $23
Moomoo NewsDec 17 09:31 ET · Ratings
DENTSPLY SIRONA (XRAY) Receives a Buy From Morgan Stanley
TipRanksDec 17 08:35 ET · Ratings
Worst Performing Stocks for Tax Loss Selling – Wolfe
Seeking AlphaDec 16 14:59 ET
Dentsply Sirona To Go Ex-Dividend On December 27th, 2024 With 0.16 USD Dividend Per Share
Moomoo NewsDec 13 20:35 ET

Comments

Moomoo AI

Feb 16 08:24

The company's low growth and lack of profits have led to a stock price drop. A revenue growth acceleration might boost the share price. However, the real benefit for shareholders will be if the company starts making profits. Despite recent gains, the returns over the last three years have been disappointing.

DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago

1

Moomoo AI

Jan 29 07:51

DENTSPLY SIRONA's decreasing capital employment and flat returns are concerning. The stock's decline may reflect investor pessimism about these trends. The analysis does not see the traits of a multi-bagger in this stock.

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Moomoo AI

Dec 24, 2023 08:55

DENTSPLY SIRONA's decision to pay a dividend amidst a reported loss is unsettling. It's not an ideal choice for long-term buy and hold investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Goes Ex-Dividend Soon

1

Moomoo AI

Dec 18, 2023 13:16

Investors predict limited future growth for the company, reflected by its low P/S ratio. The pessimism around its revenue prospect contributes to its undervalued stock.

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Moomoo AI

Nov 28, 2023 05:33

DENTSPLY SIRONA, currently undervalued with steady price trends, could make a solid investment. Despite modest growth projections, aspects like capital structure and management track record could be behind its undervaluation.

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$31.48?

XRAY Dentsply Sirona

Trade Overview

Capital Trend

News

Comments